Anthony E. Carpanzano
11Patents
3h-index
10Co-inventors
57Inventor score
Filing activity: Nov 2, 1988 → Nov 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4996047A | Sustained release drug-resin complexes | Human Necessities | 170 | Expired |
| US7384653B2 | Oral dosage form comprising a therapeutic agent and an adverse-effect agent | Human Necessities | 77 | Expired |
| US8394812B2 | Sustained release formulations of nalbuphine | Human Necessities | 6 | Active |
| USRE45822E1 | Oral dosage form comprising a therapeutic agent and an adverse-effect agent | General | 2 | Active |
| US9186330B2 | Sustained release formulation of nalbuphine | Human Necessities | 1 | Active |
| US8771732B2 | Sustained release formulations of nalbuphine | Human Necessities | 1 | Active |
| US9351938B2 | Sustained release formulation of nalbuphine | Human Necessities | 1 | Active |
| US8765175B2 | Sustained release formulation of nalbuphine | Human Necessities | 1 | Active |
| US10172798B2 | Sustained release formulation of nalbuphine | Human Necessities | 0 | Active |
| US10406106B2 | Sustained release formulations of nalbuphine | Human Necessities | 0 | Active |
| US10166185B2 | Excipient and oral solid dosage forms for oily drugs | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.